Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

34.75
+0.20000.58%
Post-market: 34.810.0600+0.17%19:30 EDT
Volume:5.44M
Turnover:187.00M
Market Cap:21.69B
PE:27.47
High:35.02
Open:34.39
Low:33.73
Close:34.55
52wk High:35.91
52wk Low:23.62
Shares:624.06M
Float Shares:617.00M
Volume Ratio:1.25
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.64
PE(LYR):22.61

Loading ...

Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook

TIPRANKS
·
Jun 12

Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits

MT Newswires Live
·
Jun 11

Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress

TIPRANKS
·
Jun 11

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 11

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 09

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04

Wells Fargo Gives a Buy Rating to Genmab (GMAB)

TIPRANKS
·
Jun 02

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Genmab A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

Genmab assumed with a Buy at Truist

TIPRANKS
·
May 27

Genmab (GMAB) Has a New Rating from Truist Financial

TIPRANKS
·
May 27

Genmab : Truist Securities Assumes Coverage With Buy Rating; Target Price $40 VS $48

THOMSON REUTERS
·
May 27

Genmab A/S Stock Rises Tuesday, Outperforms Market

Dow Jones
·
May 27

Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)

TIPRANKS
·
May 26

Wells Fargo Keeps Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
May 26

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
May 23

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
May 21

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 19

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
May 14

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
May 12